Oxford Nanopore Technologies - ONT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 429.75
  • Forecasted Upside: 58.00%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
GBX 272
▲ +3 (1.12%)

This chart shows the closing price for ONT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oxford Nanopore Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONT

Analyst Price Target is GBX 429.75
▲ +58.00% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Oxford Nanopore Technologies in the last 3 months. The average price target is GBX 429.75, with a high forecast of GBX 529 and a low forecast of GBX 390. The average price target represents a 58.00% upside from the last price of GBX 272.

This chart shows the closing price for ONT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Oxford Nanopore Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/4/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/3/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/2/2023

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/26/2023Berenberg BankReiterated RatingBuyGBX 529
4/17/2023Berenberg BankReiterated RatingBuyGBX 529
3/23/2023JPMorgan Chase & Co.Lower TargetOverweightGBX 460 ➝ GBX 390
3/22/2023Berenberg BankReiterated RatingBuyGBX 529
2/7/2023BarclaysLower TargetOverweightGBX 420 ➝ GBX 400
10/17/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
10/11/2022JPMorgan Chase & Co.Reiterated RatingOverweight
9/16/2022Berenberg BankReiterated RatingBuyGBX 671
8/8/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
8/8/2022Berenberg BankReiterated RatingBuyGBX 671
7/6/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
7/6/2022Berenberg BankReiterated RatingBuyGBX 671
6/8/2022Berenberg BankReiterated RatingBuyGBX 671
5/31/2022BarclaysLower TargetOverweightGBX 700 ➝ GBX 500
5/20/2022Berenberg BankReiterated RatingBuyGBX 671
5/9/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
3/29/2022JPMorgan Chase & Co.Lower TargetOverweightGBX 790 ➝ GBX 710
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 700
3/17/2022Berenberg BankReiterated RatingBuyGBX 662
3/15/2022BarclaysReiterated RatingOverweightGBX 700
2/4/2022Royal Bank of CanadaReiterated RatingOutperformGBX 750
2/3/2022Berenberg BankReiterated RatingBuyGBX 662
1/12/2022JPMorgan Chase & Co.Reiterated RatingOverweight
1/10/2022Royal Bank of CanadaLower TargetOutperformGBX 800 ➝ GBX 750
1/4/2022JPMorgan Chase & Co.Boost TargetOverweightGBX 725 ➝ GBX 790
12/16/2021BarclaysReiterated RatingOverweightGBX 700
12/3/2021Berenberg BankReiterated RatingBuyGBX 662
12/2/2021Royal Bank of CanadaReiterated RatingOutperformGBX 800
11/19/2021Royal Bank of CanadaReiterated RatingOutperformGBX 800
11/10/2021Berenberg BankInitiated CoverageBuyGBX 662
11/10/2021JPMorgan Chase & Co.Initiated CoverageOverweightGBX 725
11/10/2021Royal Bank of CanadaInitiated CoverageOutperformGBX 800
11/10/2021BarclaysInitiated CoverageOverweightGBX 700
(Data available from 6/2/2018 forward)

News Sentiment Rating

0.71 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/4/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/4/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/3/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/2/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/4/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
4/3/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/3/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/2/2023

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Oxford Nanopore Technologies logo
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
Read More

Today's Range

Now: GBX 272
Low: 267
High: 272

50 Day Range

MA: GBX 229.19
Low: 189.56
High: 269

52 Week Range

Now: GBX 272
Low: 169.60
High: 372.50

Volume

517,524 shs

Average Volume

1,041,771 shs

Market Capitalization

£2.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Nanopore Technologies?

The following sell-side analysts have issued research reports on Oxford Nanopore Technologies in the last twelve months: Barclays PLC, Berenberg Bank, JPMorgan Chase & Co., and Royal Bank of Canada.
View the latest analyst ratings for ONT.

What is the current price target for Oxford Nanopore Technologies?

4 Wall Street analysts have set twelve-month price targets for Oxford Nanopore Technologies in the last year. Their average twelve-month price target is GBX 429.75, suggesting a possible upside of 58.0%. Berenberg Bank has the highest price target set, predicting ONT will reach GBX 529 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of GBX 390 for Oxford Nanopore Technologies in the next year.
View the latest price targets for ONT.

What is the current consensus analyst rating for Oxford Nanopore Technologies?

Oxford Nanopore Technologies currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ONT will outperform the market and that investors should add to their positions of Oxford Nanopore Technologies.
View the latest ratings for ONT.

What other companies compete with Oxford Nanopore Technologies?

Other companies that are similar to Oxford Nanopore Technologies include Genus, Abcam, BTG, PureTech Health and Indivior. Learn More about companies similar to Oxford Nanopore Technologies.

How do I contact Oxford Nanopore Technologies' investor relations team?

The company's listed phone number is 44 84 5034 7900. The official website for Oxford Nanopore Technologies is nanoporetech.com. Learn More about contacing Oxford Nanopore Technologies investor relations.